Year 2026 / Volume 118 / Number 2
Editorial
Liver transplantation for neuroendocrine tumor metastases

67-70

DOI: 10.17235/reed.2026.11374/2025

Andrea Boscà Robledo, Eva María Montalvá Orón, Rafael López-Andújar,

Abstract
The indication for liver transplantation in liver metastases from neuroendocrine tumors is to improve overall survival and disease-free survival in these patients. The selection criteria for candidates are strict, and although few patients can benefit, it should be offered in indicated cases and patients should be referred to centers with experience in transplantation and in this type of tumor.
New comment
Comments
No comments for this article
References
1. Kuncewicz M, Jaszczyszyn IP, Karaban K, et al. Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors. Ann Transplant. 2023; 21;28:e941212.
2. Sharma A, Muralitharan M, Ramage J, et al. Current Management of Neuroendocrine Tumour Liver Metastases. Curr Oncol Rep. 2024; 26(9): 1070-1084.
3. Pavel M, O'Toole D, Costa FR, et al.Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology. 2016;103(2):172-85.
4. Pavel M, Öberg K, Falconi M, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7):844-860.
5. Muttillo EM, Mazzarella G, Picardi B, et al. Treatment strategies for neuroendocrine liver metastases: a systematic review. HPB (Oxford). 2022; 24(11):1832-1843.
6. Kaltsas G, Caplin M, Davies P, et al. Antibes Consensus Conference participants. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 2017;105(3):245-254.
7. Eshmuminov D, Studer DJ, Lopez Lopez V, et al. Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal. Ann Surg. 2023; 1;277(5):e1063-e1071.
8. Maspero M, Rossi RE, Sposito C et al. Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria. Am J Transplant. 2022; 22(11):2598-2607.
9. Elias D, Lefevre JH, Duvillard P, et al. Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think.. Ann Surg. 2010;251(2):307-10.
10. Battistella S, Grasso M, Catanzaro E, et al. Evolution of Liver Transplantation Indications: Expanding Horizons. Medicina (Kaunas). 2024; 28;60(3):412.
11. Mazzaferro V, Sposito C, Coppa J, et al. The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors. Am J Transplant 2016; 16:2892–2902
12. Dasari BVM, Line PD, Sapisochin G, et al. Liver transplantation as a treatment for cancer: comprehensive review. BJS Open. 2025; 7;9(3):zraf034.
13. Organ Procurement & Transplantation Network (OPTN). United Network for Organ Sharing (UNOS). Guidance to liver transplant programs and the National Liver Review Board for: adult MELD exception for Transplant Oncology. 2025.
14. Jackson T, Darwish M, Cho E, et al. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Abdom Radiol (NY). 2021; 46(7):3179-3183
15. Babazadeh NT, Schlund DJ, Cornelius T, et al. Should 68Ga-DOTATATE PET/CT be Performed Routinely in Patients with Neuroendocrine Tumors Before Surgical Resection? World J Surg. 2020; 44(2):604-611.
16. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47(4):460-6.
17. Fan ST, Le Treut YP, Mazzaferro V, et al. Liver transplantation for neuroendocrine tumour liver metastases. HPB (Oxford). 2015;17(1):23-8.
18. Palaniappan V, Li CH, Frilling A, et al. Long-Term Outcomes of Liver Transplantation for the Management of Neuroendocrine Neoplasms: A Systematic Review. J Pers Med. 2023. 23;13(10):1428.
19. Valvi D, Mei X, Gupta M, et al. Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors. J Gastrointest Surg. 2021;25(6):1487-1493.
20. Clift AK, Hagness M, Lehmann K, et al. Transplantation for metastatic liver disease. J Hepatol. 2023; 78(6):1137-1146.
21. Caplin ME, Pavel M, Phan AT, et al. Lanreotide autogel/depot in advanced enteropancreatic neuroendo- crine tumours: final results of the CLARINET open-label extension study. Endocrine 2021;71(2):502–513.
22. Strosberg JR, Caplin ME, Kunz PL, et al. (177)Lu-Dotatate plus long-acting octreotide versus high-dose long- acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol 2021;22(12):1752–1763.
23. Le Treut YP, Grégoire E, Klempnauer J, et al. For ELITA. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013 May;257(5):807-15.
24. Sposito, C.; Rossi, R.E.; Monteleone, M, et al. Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors. Transplantation. 2021; 105, 2579–2586.
25. Parghane RV, Bhandare M, Chaudhari V, et al. Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant 177Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors. J Nucl Med. 2021;62(11): 1558-1563.
Related articles

Editorial

Early liver transplantation in severe alcohol-associated hepatitis

DOI: 10.17235/reed.2024.10881/2024

Letter

Abernethy syndrome as a cause of liver transplantation

DOI: 10.17235/reed.2024.10561/2024

Letter

Surgical indication of type I gastric neuroendocrine tumors

DOI: 10.17235/reed.2023.9681/2023

Letter

Carcinoid syndrome and somatostatin analogues

DOI: 10.17235/reed.2023.9525/2023

Letter

Intra-abdominal epithelioid angiosarcoma

DOI: 10.17235/reed.2022.8878/2022

Digestive Diseases Image

Posterior reversible encephalopathy syndrome (PRES) in post liver transplantation

DOI: 10.17235/reed.2022.8694/2022

Letter

Ertapenem neurotoxicity in liver transplantation

DOI: 10.17235/reed.2021.8469/2021

Digestive Diseases Image

Ischemic cholangiopathy following hepatic artery pseudoaneurysm with thrombosis

DOI: 10.17235/reed.2021.8395/2021

Digestive Diseases Image

Endoscopic resection of a duodenal neuroendocrine tumor

DOI: 10.17235/reed.2021.8232/2021

Letter

Unexpected diagnosis for nodular hepatic lesions

DOI: 10.17235/reed.2021.8230/2021

Letter

EBVMCU in a liver-transplant patient

DOI: 10.17235/reed.2021.8064/2021

Digestive Diseases Image

Percutaneous treatment of a splenorenal shunt with an atrial septal closure device

DOI: 10.17235/reed.2020.7701/2020

Review

Physical frailty in liver transplantation

DOI: 10.17235/reed.2020.7448/2020

Letter

Management of hepatic artery aneurysms

DOI: 10.17235/reed.2020.7219/2020

Digestive Diseases Image

Epithelioid hemangioendothelioma: a rare cause of a liver tumor

DOI: 10.17235/reed.2020.7127/2020

Digestive Diseases Image

A rare cause of extrahepatic biliary tract stricture: a neuroendocrine carcinoma

DOI: 10.17235/reed.2020.6491/2019

Letter to the Editor

Author´s reply: Cystic pancreatic neuroendocrine tumors. A diagnostic challenge

DOI: 10.17235/reed.2018.5415/2017

Letter to the Editor

Post-transplant lymphoproliferative disease after liver transplantation

DOI: 10.17235/reed.2017.5387/2017

Letter to the Editor

Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

DOI: 10.17235/reed.2017.4997/2017

Letter to the Editor

Pancreatic neuroendocrine tumors. Prognostic factors

DOI: 10.17235/reed.2017.5109/2017

Letter to the Editor

Pancreatic neuroendocrine tumors

DOI: 10.17235/reed.2017.4725/2016

Editorial

Pancreas neuroendocrine tumors - not so rare or benign

DOI: 10.17235/reed.2016.4672/2016

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Citation tools
Boscà Robledo A, Montalvá Orón E, López-Andújar R. Liver transplantation for neuroendocrine tumor metastases. 11374/2025


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 25 visits.
This article has been downloaded 2 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 29/05/2025

Accepted: 12/06/2025

Online First: 19/01/2026

Published: 09/02/2026

Article Online First time: 235 days

Article editing time: 256 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2026 y Creative Commons. The Spanish Journal of Gastroenterology